6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
3m ago	COPLUS Accelerates AIoT Transition: Capturing High-Margin Mobility Markets via NVIDIA Ecosystem
3m ago	Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa
4m ago	Algorhythm Holdings to Present at the Market Movers Investor Summit
4m ago	Universal Technical Institute Adds Herc Rentals to Its Work and Learn Program
4m ago	Enterprise Group Announces Canada's First Fully Powered Drilling Operation Utilizing Natural Gas Turbines

About

Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) — investor relations, events, news, and company updates on 6ix.

Latest News

EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments

EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema

EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026

EyePoint Appoints Michael Campbell as Chief Commercial Officer

EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Financials

Revenue

$31.37 M

Market Cap

$1.12 B

EPS

-3.17

Community Chat

Ask AI